妊娠滋养细胞肿瘤临床分期与预后评分系统应用及其争议

Controversial issues of clinical staging and prognostic scoring system for gestational trophoblastic disease

国际妇产科联盟(FIGO)于2000年审定并通过了妊娠滋养细胞肿瘤的临床分期及预后评分标准,该文主要介绍了其分期、预后评分系统及在临床中的应用价值,以及该分期、预后评分系统在临床应用中存在争议的问题。

International federation of gynecology and obstetrics （FIGO） instituted clinical staging system and the modified scoring system in 2000. This system has been used globally for more than ten years. This article give a brief introduction of the clinical use and the controversy of this system.